Acasti Pharma Inc. Business Finance Contracts & Agreements
17 Contracts & Agreements
- Note Agreements (8 contracts)
- Purchase Agreements (1)
- Stock Agreements (6)
- Warrant Agreements (2)
- Form of 2024 NSO Stock Option Award Agreement (Filed With SEC on June 27, 2024)
- Form of 2024 ISO Stock Option Award Agreement (Filed With SEC on June 27, 2024)
- Form of Securities Purchase Agreement, dated September 24, 2023, by and between the Company and each of the Purchasers signatory thereto (Filed With SEC on September 26, 2023)
- Form of Pre-Funded Warrant, dated September 25, 2023 (Filed With SEC on September 26, 2023)
- Form of Common Warrant, dated September 25, 2023 (Filed With SEC on September 26, 2023)
- Form of Stock Option Agreement for Non-Employee Directors under the Acasti Pharma Stock Option Plan (Filed With SEC on August 11, 2023)
- Form of Stock Option Agreement for Employees under the Acasti Pharma Inc. Stock Option Plan (Filed With SEC on August 11, 2023)
- Acasti Pharma Inc., Stock Option Plan, as amended June 24, 2021 (Filed With SEC on June 21, 2022)
- Form of Second Amendment to 2018 Convertible Note Purchase Agreements and Amendment to Convertible Promissory Notes (Filed With SEC on July 1, 2021)
- Form of Amendment to 2018 Convertible Note Purchase Agreements (Filed With SEC on July 1, 2021)
- Form of Amendment to 2017 Convertible Note Purchase Agreement and Amended and Restated Convertible Promissory Notes (Filed With SEC on July 1, 2021)
- Form of 2017 Convertible Note Purchase Agreement (Filed With SEC on July 1, 2021)
- Form of 2018 Convertible Note Purchase Agreement (Filed With SEC on July 1, 2021)
- Form of 2017 Amended and Restated Convertible Promissory Note (Filed With SEC on July 1, 2021)
- Form of 2017 Convertible Promissory Note (Filed With SEC on July 1, 2021)
- Form of 2018 Convertible Promissory Note (Filed With SEC on July 1, 2021)
- Acasti Pharma Inc., Stock Option Plan, as amended August 27, 2020 (Filed With SEC on June 22, 2021)
